# OnCo record debiopharm (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/debiopharm/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "debiopharm" ;
  schema:name "Debiopharm"@en ;
  schema:description "Debiopharm is the private Swiss developer of the WEE1 inhibitor zedoresertib (Debio 0123) and of dual-payload ADC research."@en ;
  schema:url <https://onco.cc/companies/debiopharm/>, <https://www.debiopharm.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Debiopharm> ;
  owl:sameAs <http://www.wikidata.org/entity/Q3020834> ;
  schema:citation <https://www.debiopharm.com/drug-development/press-releases/debiopharm-to-unveil-new-pre-clinical-and-clinical-research-advances-in-ddr-inhibition-dual-payload-adcs-and-ai-driven-biomarkers-at-aacr-2026/> ;
  schema:addressCountry "CH" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/sclc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/synthetic-lethality-approaches/>, <https://onco.cc/technologies/dual-payload-adc/> ;
  onco:targets <https://onco.cc/targets/wee1/>, <https://onco.cc/targets/tp53/> ;
  onco:trials <https://onco.cc/trials/nct05765812/>, <https://onco.cc/trials/nct06969430/> .